Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Piraino

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Oncology Letters|January 28, 2015
Lung cancer and concurrent or sequential lymphoma: Two case reports with hypersensitivity to bevacizumab and a review of the literatureAldo Pezzuto, Alessio Piraino, Salvatore Mariotta
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 25, 2005
Azygous vein anomaly in a lung cancer patientKenji Kawamukai, Alfredo Cesario, Alessio Piraino, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 23, 2025
Relative particle size and distribution of inhaled triple therapiesBrian Lipworth, Enrico Zambelli, Ruben Agazzi, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 26, 2026
In silico Lung Deposition Profiles of Three Single-Inhaler Triple Therapies in Patients with COPD Using Functional Respiratory Imaging [Letter]Enrico Zambelli, Louise Warner, Jennifer Richards, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 4, 2021
The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease (COPD) in an Italian Context of Real Life: The TRITRIAL Study ProtocolLuca Richeldi, Alessio Piraino, Francesco Macagno, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 2, 2020
Day and Night Control of COPD and Role of Pharmacotherapy: A ReviewAlberto Braghiroli, Fulvio Braido, Alessio Piraino, et al.
Therapeutics and Clinical Risk Management|October 10, 2022
Impulse Oscillometry, Small Airways Disease, and Extra-Fine Formulations in Asthma and Chronic Obstructive Pulmonary Disease: Windows for New OpportunitiesAlfredo Chetta, Nicola Facciolongo, Cosimo Franco, et al.
Therapeutic Advances in Respiratory Disease|January 19, 2022
Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolutionFulvio Braido, Angelo G Corsico, Davide Paleari, et al.
The Clinical Respiratory Journal|July 14, 2019
Effect of OSAS on cerebral vasoreactivity and cIMT before and after CPAP treatmentAlessio Piraino, Giuliano Sette, Michela D'Ascanio, et al.
Pulmonary Therapy|February 4, 2021
Beclomethasone/Formoterol in Extra-Fine Formulation Improves Small Airway Dysfunction in COPD PatientsRoberta Pisi, Marina Aiello, Alessio Piraino, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Oncology Letters|January 28, 2015
Lung cancer and concurrent or sequential lymphoma: Two case reports with hypersensitivity to bevacizumab and a review of the literatureAldo Pezzuto, Alessio Piraino, Salvatore Mariotta
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 25, 2005
Azygous vein anomaly in a lung cancer patientKenji Kawamukai, Alfredo Cesario, Alessio Piraino, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 23, 2025
Relative particle size and distribution of inhaled triple therapiesBrian Lipworth, Enrico Zambelli, Ruben Agazzi, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 26, 2026
In silico Lung Deposition Profiles of Three Single-Inhaler Triple Therapies in Patients with COPD Using Functional Respiratory Imaging [Letter]Enrico Zambelli, Louise Warner, Jennifer Richards, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 4, 2021
The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease (COPD) in an Italian Context of Real Life: The TRITRIAL Study ProtocolLuca Richeldi, Alessio Piraino, Francesco Macagno, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 2, 2020
Day and Night Control of COPD and Role of Pharmacotherapy: A ReviewAlberto Braghiroli, Fulvio Braido, Alessio Piraino, et al.
Therapeutics and Clinical Risk Management|October 10, 2022
Impulse Oscillometry, Small Airways Disease, and Extra-Fine Formulations in Asthma and Chronic Obstructive Pulmonary Disease: Windows for New OpportunitiesAlfredo Chetta, Nicola Facciolongo, Cosimo Franco, et al.
Therapeutic Advances in Respiratory Disease|January 19, 2022
Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolutionFulvio Braido, Angelo G Corsico, Davide Paleari, et al.
The Clinical Respiratory Journal|July 14, 2019
Effect of OSAS on cerebral vasoreactivity and cIMT before and after CPAP treatmentAlessio Piraino, Giuliano Sette, Michela D'Ascanio, et al.
Pulmonary Therapy|February 4, 2021
Beclomethasone/Formoterol in Extra-Fine Formulation Improves Small Airway Dysfunction in COPD PatientsRoberta Pisi, Marina Aiello, Alessio Piraino, et al.
Pageof 5